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Abstract
The current study aims to investigate the effects of matrine on the JAK-STAT signaling transduction pathways in
bleomycin (BLM)-induced pulmonary fibrosis (PF) and to explore its action mechanism. A total of 72 male C57BL/6 mice
were randomized into the control, model, and treatment groups. PF models were established by instilling BLM intratracheally.
The treatment group was given daily matrine through gastric lavage. Six mice were sacrificed in each group at 3, 7, 14, and
28 days. The lung tissues were observed using hematoxylin-eosin staining. The expression of JAK, STAT1, and STAT3 was
observed using immunohistochemistry and then determined using real-time polymerase chain reaction. Alveolitis and PF
significantly improved in the treatment group compared with the model group (P < 0.05). The expression of JAK, STAT1,
and STAT3 in the model group increased at day 7, peaked at day 14 and then decreased, but the expression was still higher
than that in the control group at day 28 (P < 0.05). The three indices in the treatment group were significantly lower than
those in the model group at any detection time point (P < 0.05). PF causes high expression of JAK, STAT1, and STAT3.
Matrine exerts an anti-PF effect by inhibiting the JAK-STAT signaling transduction pathways.
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Introduction
Idiopathic pulmonary fibrosis (PF) is primarily manifested by interstitial cell hyperplasia and the excessive deposition
of extracellular matrixes dominated by collagen proteins (Gross and Hunningghake, 2001). The incidence of IPF has shown
an increasing trend in recent years, but effective therapies aiming at increasing the survival rate of IPF patients and their
clinical symptoms have not yet been confirmed. The fast development of the techniques in cytology and molecular biology
has shed new light on the pathogenesis of PF (Hwang et al., 2005; Jack et al., 1990; Kaminski and Rosas, 2006). Signal
transducers and activators of transcription (STATs) are a group of transcription factors which are activated by polypeptide
ligands such as cytokines, as well as important substrates of receptor associated protein tyrosine kinases Janus Kinases/Just
another Kinases (JAKs). Different JAK-STAT pathways are activated by different cytokines (Ratthe et al., 2007). Among
these pathways, the activation of JAK-STAT3 is closely correlated with the occurrence of fibrotic diseases, thus, inhibitors of
this pathway are promising to become the target of new drugs developed for these diseases (Ahn et al., 2009; Tu et al., 2005).
Lightyellow sophora root is the dried root of Sophora flavescens ait (leguminosae). It is bitter in taste and cold in nature.
Matrine is the major active component of the alkaloids of Sophora flavescens ait, and it has multiple pharmacologic actions
and effects (Cao et al., 2010; Jiang et al., 2007; Liu et al., 2007; Yang et al., 2007). Matrine has a definite anti-liver fibrosis
action and thus has been extensively applied in the treatments of chronic hepatitis, dermatofibrosis, and liver fibrosis (Gao
and Law, 2009; Li et al., 2007). In the process of the initiation of PF, the mechanism of free radical injury plays a crucial role.
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Matrine can clear the free radicals with cytotoxic effect and inhibit the division and proliferation of firbroblasts thereby to
exert anti-tissue damage and PF-preventing effects. However, whether matrine exerts these effects by influencing JAK-STAT
signaling transduction pathways remains uncertain, and no report on this issue exists in literature.
In the current study, to investigate the specific effects of matrine on the JAK-STAT1 and JAK-STAT3 signaling
transduction pathways, mouse models with PF were established with bleomycin (BLM). This study is intended to find the
target of specific actions on the JAK-STAT signaling transduction pathways and to provide an experimental basis for the
treatment of PF.
Materials and Methods
Animals
A total of 72 healthy male C57BL/6 mice, aging 8 weeks and weighing 20 g to 22 g, were supplied by Shanghai Slac
Laboratory Animal Co., Ltd., China. This study was conducted in strict accordance with the recommendations in the Guide
for the Care and Use of Laboratory Animals of the National Institutes of Health, and the animal use protocol was reviewed
and approved by the Institutional Animal Care and Use Committee (IACUC) of College of Medicine Jiangsu University.
Grouping and medications
The animals were randomized into the control, PF model, and treatment groups. The mouse was immobilized in a
supine position after an abdominal anesthesia with 1.5% pentobarbital sodium. The neck was disinfected, and successive
separation was performed to expose the trachea. An injector was inserted into the trachea in the direction of the heart through
the tracheal cartilage ring gap for BLM infusion (5 mg/kg). The control group was given the same volume of physiological
saline. After the infusion, the animal was straightened and rotated left and right immediately for an even distribution of the
liquid in the lungs. At 24 h after model establishment, the control and model groups were subjected to gastric lavage with
physiological saline, whereas the treatment group with matrine (25 mg/kg) (Ratthe et al., 2007) once daily. Six mice were
killed in each group at 3, 7, 14, and 28 days.
Cell culture and inhibition action
Human lung fibroblasts (LFs) MRC-5 were cultured with DMEM containing 10% FBS in 5% CO2 at 37 °C. When the
bottom of the culture bottle was covered by LF-like cells, 0.25% trypsin was applied for generations. The fourth generation
was used. The cells were prepared into 1 × 104/ml monoplast suspension and then inoculated onto a 96-well plate for 24-h
culture. They were divided into the control, model, and matrine (0.8 mmol/l) (Jiang and Xie, 2010) groups and then
medicated separately for 1, 3, 5, and 7 days. MTT solution at 20 µl, prepared with 5 mg/ml PBS of pH 7.4, was added into
each well for 4 h of culture. The culture supernatant was discarded carefully (supernatants containing suspension cells had to
be removed after centrifugation). 150 µl of DMSO was added into each well. The solution was oscillated for 10 min to solve
the crystals completely. The light absorption value of each well at a wavelength of 490 nm was read using an enzyme
immunoassay instrument.
Hematoxylin-eosin (HE) staining and immunohistochemistry
After sacrifice, part of the lung tissue was fixed in 4% neutral formalin. It was routinely dehydrated, embedded and
then sectioned for HE staining. Immunohistochemistry was performed for protein expression observation using the Strept
avidin-biotin complex method. Part of the lung tissue was taken after sacrifice. It was fixed in 10% formalin overnight,
Ma et al., Afr J Tradit Complement Altern Med. (2013) 10(3):442-448
http://dx.doi.org/10.4314/ajtcam.v10i3.10
444
routinely dehydrated, cleared, embedded in paraffin, serially sectioned (5 μm), dewaxed and afterwards dried. The 
immuohistostaining of JAK, STAT1, and STAT3 was performed according to the instructions indicated in the kit (Wuhan
Boster Bio-engineering Limited Company, China). Cells with brown- or buffy-stained cytoplasm or nucleus were recorded
positive.
Reverse transcription polymerase chain reaction (RT-PCR)
Total RNA extraction and cDNA synthesis were performed according to kit instructions. Semi-quantitative PCR
primers were designed according to JAK, STAT1, and STAT3 cDNA sequence in NCBI. The internal control GAPDH primer
was 5'-AATCCCATCACCATCTTCCA-3 ' and 5'-CCTGCTTCACCACCTTCTTG-3'. For the PCR reaction, 1 μl of cDNA, 2 
μl of primer, and 10 μl of 2 × PCR Master Mix were added to 20 μl of ddH2O. The reaction conditions were as follows: 95 °C
denaturation for 1 min, 95 °C denaturation for 30 s, 60 °C annealing for 30 s, 68 °C extension for 90 s, 25 cycles, and 68 °C
fully extended to 10 min. The PCR products were detected using 1.5% agarose gel electrophoresis, and scanned by a gel
imaging analysis system camera. The band density was analyzed by the ScnImage software.
Statistical analysis
Data were presented as means ± standard error of means (x ± s). They were analyzed using the SPSS12.0 software.
Tukey’s tes was performed to compare the mean values between groups.
Results
Inhibitory effect of matrine on LFs
Matrine had a significant inhibitory effect on LFs, compared with the model group (P < 0.05; Table 1).
Pathological changes in the lung tissues
In the control group, the lung tissues had clear structures without noticeable pathological changes. In the model group,
noticeable alveolitis occurred in the tissues, with exudative changes in the pulmonary alveoli at day 3; at day 7, exudation
turned more serious and inflammatory cell infiltration appeared; from 14 day to 28 day, although alveolitis and exudation
eased gradually, fibrosis aggravated gradually with noticeably increased alveolar septa, most alveolar structures were
destroyed and pulmonary alveoli varied in volume. In the treatment group, the change from alveolitis to fibrosis also took
place, but with a less degree, compared with that in the model group; inflammation and fibrosis were also less serious
compared with those in the model group. The results are shown in Figure 1.
The expression of JAK, STAT1, and STAT3
In the control group, STAT1 and STAT3 were only lowly expressed in part of inflammatory cells. Compared with the
control group, the model group exhibited noticeably deepened JAK and STAT1 staining: significantly increased expression
in inflammatory cells and widely deeply-stained epithelial cells; STAT3 expression also greatly increased, which was
principally localized in alveolar macrophages and partially localized in endothelial cells and neutrophils. In the treatment
group, however, the expression of JAK, STAT1, and STAT3 significantly decreased compared with that in the model group.
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RT-PCR
The RT-PCR demonstrated that the mRNA expression of JAK, STAT1, and STAT3 in the lung tissues of the model
Figure 1: Pathological changes in the lung tissues (HE staining, × 400).
Table 1. Inhibitory effect of matrine on PF cells (

x ± s, n = 6)
Time (d)Groups
1 3 5 7
Control 0.227 ± 0.022 0.275 ± 0.023 0.237 ± 0.030 0.223 ± 0.022
Model 0.518 ± 0.025* 0.74 7± 0.027* 0.812 ± 0.036* 0.892 ± 0.025*
Matrine 0.502 ± 0.027 0.472 ± 0.023** 0.415 ± 0.038** 0.346 ± 0.022**
*P < 0.05 compared with the control group, and ** P < 0.05 compared with the model
group.
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Table 3 STAT1 mRNA expression of the control, model, and treatment groups (

x ± s,
n = 6)
STAT1 mRNA expressionGroups
7 d 14 d 21 d 28 d
Control 0.147 ± 0.018 0.168 ± 0.015 0.161 ± 0.014 0.161 ± 0.019
Model 0.195 ± 0.023 0.674 ± 0.086* 0.521 ± 0.022* 0.421 ± 0.052*
Matrine 0.122 ± 0.014 0.456 ± 0.058** 0.392 ± 0.023** 0.274 ± 0.033**
*P < 0.05 compared with the control group, and ** P < 0.05 compared with the model
group.
Table 4 STAT3 mRNA expression of the control, model, and treatment groups (

x ± s,
n = 6)
STAT3 mRNA expressionGroups
7 d 14 d 21 d 28 d
Control 0.524 ± 0.064 0.599 ± 0.076 0.574 ± 0.057 0.574 ± 0.071
Model 0.696 ± 0.085 2.401 ± 0.307* 1.854 ± 0.185* 1.498 ± 0.185*
Matrine 0.436 ± 0.053 1.624 ± 0.207** 1.397 ± 0.139** 0.976 ± 0.121**
*P < 0.05 compared with the control group, and ** P < 0.05 compared with the model
group.
group was significantly higher than that in the control group, whereas their mRNA expression in the treatment group was
noticeably lower than that in the model group (P < 0.05). The results are shown in Tables 2-4,.
Table 2 JAK mRNA expression of the control, model, and treatment groups (

x ± s, n
= 6)
JAK mRNA expressionGroups
7 d 14 d 21 d 28 d
Control 0.214 ± 0.026 0.245 ± 0.031 0.235 ± 0.023 0.235 ± 0.029
Model 0.285 ± 0.034 0.982 ± 0.125* 0.758 ± 0.075* 0.613 ± 0.075*
Matrine 0.178 ± 0.021 0.664 ± 0.084** 0.571 ± 0.057** 0.399 ± 0.049**
*P < 0.05 compared with the control group, and ** P < 0.05 compared with the model
group.
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Discussion
PF is associated with JAK-STAT signaling transduction pathways (Eitzman et al., 1996; Fan et al., 2003; Kim et al.,
2002; Wang et al., 2009). These pathways are important cytokine signal transduction channels, which are involved in the
gene regulation of cytokines in biological functions such as cytopoiesis, differentiation, embryo development, and organic
immunity. JAKs are subject to a non-receptor type of tyrosine kinases and include JAK1, JAK2, JAK3, and Tyk2 as
members. The members of JAKs and STATs activated by different cytokines display differences somewhat. Cytokines bind
with their receptors and induce them to be dimerized to form combining sites for JAKs in cytoplasm; these sites activate
JAKs, and then these activated JAKs activate STATs; the activated STATs undergo dimerization and nuclear localization and
afterwards bind with specific DNA sequences to direct gene transcription (Meraz et al., 1996; Selman et al., 2004; Walters et
al., 2005). These pathways conduct the intracellular signals of cytokines or even non-immunotransmitters, which involve
varying pathophysiological processes such as immunity, cell proliferation and differentiation, apoptosis, inflammation,
tumors, and so on. JAK-STAT signaling transduction pathways play an important role in the development of fibrosis.
The present study demonstrates that matrine has an obvious inhibitory effect on PF cells. This finding is consistent with
what had been expected before the experiment. This study also showed that although the treatment group displayed a change
from alveolitis to PF as well, its inflammation and PF lesion greatly improved compared with those in the model group.
Furthermore, the immunohistochemistry and RT-PCR showed that JAK, STAT1, and STAT3 were abnormally expressed in
the model group, which reached the peaks at 14 d and were significantly higher than those in the control group even at 28 d.
These findings suggest that the JAK-STAT1 and –STAT3 pathways play important roles in the development of early alveolitis
and PF. Therefore, it is reasonable to presume that these pathways, through the abnormal expression of STAT1 and STAT3,
induce the intra-pulmonary accumulation of inflammatory cells to activate the proliferation of smooth muscle cells and
fibroblasts and then to increase collagen synthesis, ultimately leading to the occurrence of PF. In addition, this study shows
that matrine can relieve the severity of alveolitis and PF and inhibit the growth of pulmonary fibrocytes by downregulating
the abnormal expression of JAK, STAT1, and STAT3 to exert its anti-fibrosis function. This finding provides a new method
for the treatment of PF. Furthermore, by observing the changes in various signaling molecules of the JAK-STAT pathways
during the progression of PF, this study also provides a theoretical foundation for study on the roles of JAK-STAT pathways
in the development of PF, as well as a new breakthrough point for further study on the molecular mechanism of PF. However,
this study has a limitation: It merely based the influence of matrine on the JAK-STAT pathways in PF mice on the study of
the expression of proteins and nucleic acid molecules using immunohistochemistry and RT-PCR. To further clarify the
anti-PF mechanism of matrine, a planned study will use primarily cultured cells to determine the expression of various
molecules in the JAK-STAT pathways at different stages of PF induced with BLM. That study will be valuable not only in
proposing a new idea for exploration into the pathogenesis of PF but in offering a new target for PF treatment.
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